- Sure sounds like you think it is over valued. I think it is cheap right now. IMO, the sell-off had little to do with Rida and Berger and more to do with technicals, manipulation and the $6 Feb strike that expired.
-Obviously it is not going to go straight up. But up significantly in 18 months IMO.
We disagree so let's move on, this is getting boring for the board (haha). You have to at least like what you see so far in Ponatinib? Can you throw me a bone on that one?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.